Samy Cecioni

Title: Samy Cecioni: Innovator in Pharmaceutical Chemistry

Introduction

Samy Cecioni is a notable inventor based in Oullins, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Cecioni's work focuses on developing compounds that have the potential to treat various medical conditions.

Latest Patents

Cecioni's latest patents include novel pyrrolidine derivatives and glycomimetic compounds. The pyrrolidine derivatives are designed to treat a range of conditions, including epilepsy, neurodegenerative diseases, and psychiatric disorders. These compounds can exist in various forms, including zwitterionic forms and optical isomers, and are also useful in pharmaceutical compositions. The glycomimetic compounds are aimed at combating bacterial infections by targeting pathogens that utilize lectins during the infection process. These compounds are characterized by their calixarene-based glycosylated structure and are intended for use in pharmaceutical formulations.

Career Highlights

Throughout his career, Samy Cecioni has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Claude Bernard Lyon I. His research has contributed to advancements in the understanding and treatment of complex medical conditions.

Collaborations

Cecioni has collaborated with notable colleagues, including Jean-Pierre Praly and Kaiss Aouadi. These partnerships have fostered a collaborative environment that enhances the innovation process in pharmaceutical research.

Conclusion

Samy Cecioni's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new treatments and advancements in medical science.